KRAS mutant lung cancer has three variants: type-1 is a characterized by mucinous histology with TTF1 expression, type-2 is characterized by high TMB and PDL1 expression while type-3 group contains KEAP mutation [6]. The gene discussed is CD274; the disease is lung cancer.